Anal Cancer Cases And Mortality Rate Drastically Rise in The United States of America

anal cancer cases and mortality rate drastically rise in the united states of america

Anal cancer cases and deaths linked to human papillomavirus have dramatically increased in the United States over the last 15 years. Human papillomavirus is the most dangerous sexually transmitted disease. Young black men and older people are seemed to be badly affected by the dreaded disease. The researchers have compared the rising incidents of squamous cell carcinoma of the anus, which is caused HPV for the first time. They have categorized it by the stage at diagnosis, year of birth, and mortality. Experts have found out that the mortality rate in anal cancer cases has been multiplied for people in their 50s and 60s. According to experts, anal cancer is diagnosed at an advanced stage.

The study has shown a five-fold increase in anal cancer diagnoses in black men born after the mid-1980s as compared to those who were born in the 1940s. Researchers have said that rising mortality rates in anal cancer cases and distant stage diseases are a matter of high concern. This type of cancer usually occurs towards the end of the gastrointestinal tract. The location of such types of cancer makes it different from the colon or rectal cancer. Anal cancer has many similarities with cervical cancer, which targets women’s cervix.  When cancer spreads around other body parts is called distant stage disease. Such distant-stage diseases have reduced the survival rate in anal cancer diagnoses. Approximately 90 percent of anal cysts are caused by HPV.

Experts have found out 68809 cases of anal cancer after analyzing data from cancer registries in the US. As per the records, nearly 12111 people have lost their lives from 2001 to 2016 due to such type of cancer. Scientists have claimed that cancer and mortality rate have shot up by 3 percent per year. Human papillomavirus can be prevented through vaccination. However, 50 percent of Americans are not vaccinated yet. It can be a potential cause of rising incidences of anal cancer cases.  The US Centers for Disease Control and Prevention has suggested doses of regimen starting before the age of 15 and 3 doses if the treatment has started at the age of 16 until the age of 26. The vaccine is advisable for 27 to 45 years old individuals as well. However, they should consult their healthcare provider to be vaccinated. Screening of anal cancer is not being performed on a larger scale currently except for certain high-risk groups. Experts have suggested that health professionals should take efforts for the broader screening of the dreaded disease.